🏥 Clinical Tools MCP Server
Comprehensive MCP-compatible clinical decision support tools.
Connect from LM Studio:
- URL:
https://gjacob2010-mcp-server-r02.hf.space - Transport: SSE
Gestational Age ≥35 weeks
GBS Testing Already Done
Gestational Age ≥24 weeks
GDM Testing Already Done
Primary Symptom: Vasomotor symptoms Genitourinary syndrome of menopause?
Any Absolute Contraindications to Estrogen Present? Undiagnosed abnormal vaginal bleeding Known suspected or history of breast cancer Known or suspected estrogen-dependent cancers(i.e.,endometrial, ovarian) Coronary heart disease Active or history of venous thromboembolism Active or history of stroke Known thrombophilia Active liver disease Known or suspected pregnancy More than 10 years from Menopause
Contraindications for progesterone? Previous breast cancer or Patient wants to avoid risk of breast cancer all together
Does Ultrasound Meet Definitive EPL Criteria?
Positive Depression Screen?
Patient Clinically Stable Without Infection, Heavy Bleeding, Or Severe Anemia?
Patient Management Choice?
Gestational Sac Present On Ultrasound?
Is Patient Rh Negative And Gestational Age 10-12 Weeks?
First Trimester or Second Trimester Markers?
Single Mildly Abnormal Marker Only?
Two Abnormal First Trimester Markers (esp. PAPP-A <0.4 + PlGF <0.4)?
FMF Risk >1percent for Preterm Preeclampsia?
Is Patient ≤16 Weeks Gestation?
Single Mildly Abnormal Second Trimester Marker?
(PlGF <10th percentile OR sFlt-1/PlGF >95th percentile OR UA Doppler >95th percentile OR FMF risk >1%)
One Severely Abnormal Marker OR Two Mildly Abnormal Markers?
Aspirin Started?
Active Labour? (≥4 cm dilation)
Woman Requests Pain Relief?
Dystocia? (>4 hrs of <0.5 cm/hr OR no change in 2 hrs in active phase)
Full Dilation (10 cm)?
Urge to Push Present?
Second Stage Dystocia? (No descent after 1 hr active pushing OR time limits exceeded)
Baby Delivered?
Patient Type?
Pruritis of palms/soles in 2nd/3rd trimester?
Bile acid level >19 μmol/L?
Atypical presentation requiring specialist?
Symptomatic pruritis requiring treatment?
Highest bile acid level?
Reached appropriate delivery timing?
Bile acid level progression?
Comorbidities present? Multiple pregnancy, preeclampsia, GDM, previous stillbirth
Symptoms resolved at 6 weeks?
Biochemical abnormalities also persistent?
CD4 Count Status?
Viral Load Status within 4 Weeks of Delivery?
Risk Category for Neonatal Prophylaxis?
Patient Choice?
CfDNA Results?
NT Results?
Structural Findings on anatomy ultrasound
Risk factors present?
Severe symptoms?
Antidepressant indicated?
Currently on antidepressant?
Current antidepressant working well?
History of antidepressant that helped?
Good response after 4-8 weeks?
Risk Assessment Gateway
Screening Decision Gateway
Treatment Decision Gateway
Medication Selection Gateway
Follow-up Planning Gateway
Gestational Age?
Blood Typing Result?
Genotyping Result?
Clinical Scenario?
Early Pregnancy Loss Gestational Age?
Type of Invasive Procedure?
Suspected FMH Gestational Age?
Confirmed FMH Volume?
Newborn Rh Type?
Postpartum FMH Volume?
Patient At Risk for Preeclampsia?
High Risk Findings (abnormal biomarkers, Doppler, PlGF)?
FGR Suspected on Ultrasound?
Gestational Age at FGR Diagnosis?
Evidence of Fetal vs Placental Cause?
Fetal surveillance findings
Doppler results for FGR
Late-Onset FGR Severity Assessment?
Planning Future Pregnancy?
Chorionicity Confidently Confirmed?
Structural Anomaly or Abnormal Genetic Screening?
Discordant Anomaly Requiring Selective Termination?
TTTS Diagnostic Criteria: (1) Oligohydramnios in donor (DVP <2cm) AND polyhydramnios in recipient (DVP >8cm before 20wks or >10cm after 20wks), (2) Discordant bladder sizes (small/empty in donor, distended in recipient)
sFGR Diagnostic Criteria: EFW of one twin <3rd percentile OR at least 2 of following: (1) EFW <10th percentile, (2) AC <10th percentile, (3) EFW discordance ≥25%, (4) UA pulsatility index of smaller twin >95th percentile
TAPS Diagnostic Criteria: High MCA PSV (≥1.5 MoM) in donor/anaemic twin AND low MCA PSV (≤0.8 MoM) in recipient/polycythaemic twin. Alternative: MCA PSV discordance ≥1.0 MoM. Often WITHOUT significant AFV discordance
TRAP Diagnostic Criteria: Amorphous, usually edematous acardiac twin with colour Doppler showing retrograde perfusion via A-A anastomosis from healthy pump twin. NO blood flow in suspected acardiac twin
Acardiac:Pump AC Ratio ≥50% OR Cardiac Compromise?
Single Intrauterine Death?
Monoamniotic Twins?
Risk Factors Identified?
FHR Abnormal (<110 or >160 bpm or irregular)?
SFH Discordant (differs by 3cm or <10th/>90th percentile)?
NST Classification?
BPP Score?
Patient Reports Reduced Fetal Movements?
Gestational age is greater than or equal to 24 weeks
Does Patient Require IOL Assessment?
What is Clinical Scenario?
Is Patient GBS Positive?
Is EFW >4500g with Diabetes or >5000g Without Diabetes?
Is This Elective IOL at 39 Weeks Request?
Are Membranes Ruptured?
Is Patient GBS Positive?
Check Modified Bishop Score
Is Balloon Catheter Possible?
After cervical ripening method has Bishop Score Reached ≥7?
Choose Induction Method Based On Clinical Factors
Has Active Labour Started?
Using Oxytocin And Dilation ≥5cm?
Wait Appropriate Time Before Switching Agents
Cervical Length Assessment
Growth Status
First Twin Presentation
Is Delivery Expected Within 7 Days?
Gestational Age Category?
Does Patient Have Pre-Gestational Diabetes?
Risk Factors Present?
Fetal Vessels Identified?
Distance from Cervical Os?
Vasa Previa Confirmed?
Low-Lying Vessels Confirmed?
Hospitalization Indicated?
Pregnancy Type?
Pregnancy Type for Low-Lying Vessels?
Antepartum Hemorrhage or Emergency?
Bishop Score?
Outpatient eligible ?Assess Inpatient Options: compromised fetus, placental insufficiency, grand multiparity
Previous Cesarean or Uterine Scar?
Compromised Fetus?
Tachysystole Detected?
Bishop Score ≥ 7 Achieved?
Patient Needs Break During Ripening?
Group B Strep Positive?
Can Lesion Be Adequately Characterized?
Is This Normal Ovary or Physiologic Cyst?
Does Lesion Match Classic Benign Pattern?
Which Classic Benign Lesion Type?
Simple Cyst Size and Menopausal Status?
Hemorrhagic Cyst: Size and Menopausal Status?
Dermoid Cyst Size?
Endometrioma: Menopausal Status?
Is Lesion Predominantly Solid (≥80%)?
Solid Lesion: Smooth or Irregular Contour?
Smooth Solid Lesion: Shadowing and Color Score?
Cystic Lesion: Has Solid Components?
Cyst Without Solid Components: Number of Locules?
Uni/Bilocular Cyst: Smooth or Irregular?
Smooth Uni/Bilocular Cyst: Size?
Multilocular Cyst Without Solid Components: Smooth or Irregular?
Smooth Multilocular Cyst: Size and Color Score?
Cyst With Solid Components: Number of Locules?
Unilocular Cyst With Solid Components: Papillary Projections Count?
Bi/Multilocular Cyst With Solid Components: Color Score?
Check for Ascites/Peritoneal Nodules (Not Due to Other Etiologies)?
Amniotic Fluid Visible At Speculum Exam?
Diagnosis Still Equivocal?
Active Labour, Infection (Chorioamnionitis), Placental Abruption, Or Fetal Distress Present?
Is This Previable PPROM?
Patient Elects Expectant Management?
GBS Status Unknown Or Positive?
current GA
Patient Has Cervical Cerclage In Place?
current GA
current GA
GBS Colonization Present?
Patient In Active Labour Or Imminent Delivery Anticipated?
Anemia or Iron Deficiency Present?
High Risk for PPH?
Blood Loss Stage?
Placenta Delivered within 30 Min?
Uterine Inversion Present?
Bleeding Controlled with Medical Management?
Tamponade Effective?
Blood Loss Approaching MABL - Maximum Allowable Blood Loss?
Lab Results Available?
Pregnancy Status
Preeclampsia Risk Assessment High Risk Factors: Prior preeclampsia Chronic hypertension Pre-gestational diabetes mellitus Chronic kidney disease Systemic lupus erythematosus/antiphospholipid antibody syndrome Multifetal pregnancy Moderate Risk Factors: Prior placental abruption Prior stillbirth Prior fetal growth restriction Pre-pregnancy BMI >30 kg/m² Maternal age >40 years Assisted reproductive therapy Nulliparity
Blood Pressure Status
Hypertension Classification
Adverse conditions that define pre-eclampsia: Severe headache/visual symptoms Chest pain/dyspnea Oxygen saturation <97 Low platelet count (< 150) Elevated serum creatinine (>90) RUQ or epigastric pain Elevated serum AST (>90) ALT (>90) Atypical or abnormal NST/CTG FGR Oligohydramnios Absent or reversed end-diastolic flow by umbilical artery Doppler velocimetry Angiogenic imbalance
Immediate Delivery Indications Eclampsia PRES Cortical blindness or retinal detachment Glasgow coma scale <13 Stroke TIA or RIND Uncontrolled severe hypertension (over a period of 12 hours despite use of 3 antihypertensive agents) Oxygen saturation <90%, need for 50% oxygen for >1 hour intubation (other than for cesarean section) pulmonary edema Positive inotropic support Myocardial ischemia or infarction Platelet count <50 Transfusion of any blood product Acute kidney injury (creatinine >150 mM with no prior renal disease) New indication for dialysis Hepatic dysfunction (INR >2 in absence of DIC or warfarin) Hepatic haematoma or rupture Abruption with evidence of maternal or fetal compromise Absent or reversed ductus venosus a-wave by Doppler velocimetry Intrauterine fetal death
Gestational Age
Gateway: Planning Pregnancy Status
Gateway: Risk Category Assessment
Gateway: High-Risk Supplementation Approach
Gateway: Serum Folate Level Results
Gateway: Moderate Risk Category Type
Gateway: Folate Level After 1-2 Months Of 1.0 mg Supplementation
Gateway: Obesity Assessment (BMI >30 kg/m²)
Local Expertise Available?
Singleton or Multiple Pregnancy?
Chorionicity Clear on Transabdominal Scan?
Chorionicity Clear or Monochorionicity Identified?
NT Measurement greater than equal to 3.5mm or greater than equal to 99th Centile?
Pregnancy at Risk of Aneuploidy or Congenital Heart Disease?
Fetal Anomaly Detected?
History of Cesarean Delivery?
Greater than equal to 1 Placenta Accreta Spectrum Features Present? Loss of the clear zone (hypoechoic plane underneath placental bed) Presence of at least 3 placental lacunae Bladder wall interruption Uterovesical hypervascularity Non-visible cesarean scar Thin retroplacental myometrium (<1 mm)
Symptom and Risk Assessment Gateway
Seroconversion and Interpretation Gateway
Gestational Age and Infection Type Gateway
Fetal Sonography Gateway
Congenital Infection Confirmation Gateway
Management Strategy Gateway
Occupational Risk Gateway
Is The Patient Presenting With Symptoms Suggestive Of Tubal Rupture Or Hemodynamic Instability?
What Are The Ultrasound Findings And Adnexal Mass Characteristics?
Are There Absolute Contraindications To Methotrexate Therapy?
What Is The Specific Ectopic Pregnancy Site For Non-Tubal Cases?
Has The Patient Completed The Methotrexate Monitoring Period With Beta-Hcg Drop Evaluation?
What Are The Specific Post-Treatment Surveillance Requirements Based On Intervention Type?
Is Patient Access To Emergency Care And Follow-Up Reliable?
What Is The Beta-Hcg Trajectory And Initial Level Stratification For Risk Assessment?
Does the patient present with abnormal uterine bleeding > 6 weeks post-pregnancy, abnormal bleeding after termination/evacuation/spontaneous abortion, or evidence of metastatic disease?
What is the pathology diagnosis?
For Hydatidiform Mole - Is the patient age > 40 or has completed childbearing and desires definitive management?
Is the patient Rh-negative?
Does post-molar hCG monitoring meet criteria for Gestational Trophoblastic Neoplasia (GTN)? Criteria includes: Rising serum hCG level (> 10% increase for 2 consecutive weeks), Plateau in serum hCG level (< 10% change for 3 consecutive weeks), Histologic diagnosis of choriocarcinoma, Evidence of metastatic disease, Serum hCG level > 20,000 mIU/mL 4 weeks post-evacuation
What is the WHO Prognostic Score?
For Low-Risk GTN (Score 0-6) - Does the patient wish to preserve fertility or is surgery not suitable?
Does the woman or her partner have any of the following risk factors requiring higher folic acid dosage: previous NTD pregnancy, family history of NTD, personal history of folic acid-sensitive anomalies (cardiac, limb, cleft), type 1 or 2 diabetes, use of teratogenic medications (anticonvulsants), gastrointestinal malabsorption (celiac, IBD), or obesity?
Is the patient undergoing first-trimester sonographic screening (11-13 weeks) at a center with appropriate training, expertise, and evidence of follow-up?
Is the patient between 18 and 22 weeks gestation for routine anatomical sonographic examination, or does she have a pre-pregnant BMI greater than or equal to 35 kg/m2 or geographic limitations preventing timely second-trimester sonography?
Has the screening (ultrasound or MSAFP) identified a suspected open or closed neural tube defect (anencephaly, encephalocele, myelomeningocele)?
What is the specific type of neural tube defect diagnosed after confirmation and genetic testing?
For a fetus with Myelomeningocele (MMC), has the patient chosen one of the following management options: termination of pregnancy, postnatal surgical repair, or prenatal surgical repair?
Does The Patient Have Risk Factors For Impacted Fetal Head Or Is The Head Deeply Impacted (Prolonged Second Stage >3h Nulliparous Or >2h Parous Plus 1h With Epidural, Fetal Malposition, Or Failed Assisted Vaginal Birth)?
Is Pharmacological Uterine Relaxation Required (Uterus Contracted Post-Incision Or Inadequate Natural Relaxation)?
Which Uterine Incision Type Is Planned Based On The Delivery Technique?
Is The Fetus In Occiput Posterior Position (Facilitates Reverse Breech) Or Is Occiput Anterior (Requires Push/Patwardhan/Device)?
Are There Intraoperative Signs Of Maternal Or Fetal Complications (Uterine Extension, Bladder Injury, Skull Fracture, Low Apgar)?
Was The Uterine Incision Non-Standard (High Transverse, Vertical, Or T-Shaped) Requiring Specific Future Pregnancy Counseling?
Is Parental Consent For Full Autopsy Obtained
Are There Indications For Coagulation Studies - Massive Placental Abruption Or Fetal Death More Than 4 Weeks Prior To Delivery
Are Symptoms Of Pruritus Or Suspected Intrahepatic Cholestasis Of Pregnancy (ICP) Present
Do Bile Acid Levels Exceed 40 mmol/L
Is Mosaicism Or Triploidy Suspected
Are Congenital Malformations, IUGR, Hydrops, Ambiguous Genitalia, Or Dysmorphic Features Present
Is There Evidence Of Fetal Hydrops, Endomyocardial Fibroelastosis, Or Atrioventricular Node Calcification On Postmortem
Is The Fetus Hydropic, Is The Mother Anemic, Or Is Alpha-Thalassemia Suspected
Gestational Age Assessment Gateway
Placental Edge Distance Classification Gateway
Risk Factors for Urgent Delivery Assessment Gateway
Cesarean Delivery Timing Decision Gateway
Trial of Labour Eligibility Gateway
Urgent Delivery Indications Assessment Gateway
Risk Profile Assessment Gateway
Surveillance Timing Decision Gateway
Cervical Length Measurement Threshold Gateway
Symptomatic Status Check Gateway
Complication And Special Situation Check Gateway
Final Decision And Plan Gateway
Geographic And Vector Risk Assessment
Tick Attachment Duration And Engorgement Status
Clinical Symptom Assessment
Disease Stage Determination
Penicillin Allergy Status
Cardiac And Neurological Complication Check
Pregnancy And Pediatric Outcomes Assessment
Screening Indication Gateway
Infection Type Identification Gateway
Genetic Screening Strategy Gateway
HBV Viral Load Threshold Gateway
HBV Treatment Timing Gateway
HCV Procedure Selection Gateway
HIV cART Status Gateway
Procedural Safety Check Gateway
Documentation Verification Gateway
Gestational Age Eligibility Gateway
Imminent Birth Definition Gateway
Tocolysis Status Gateway
Maintenance Infusion Decision Gateway
Renal Impairment Monitoring Gateway
Duration and Imminence Check Gateway
Fetal Heart Rate Monitoring Gateway
Neonatal Resuscitation Protocol Gateway
Indication Assessment Gateway
Contraindication Check Gateway
Fetal Station and Position Gateway
Instrument Selection Gateway
Episiotomy Decision Gateway
Neonatal Hemorrhage Risk Gateway
Maternal Trauma Risk Gateway
Postpartum Care Planning Gateway
Risk Factor Assessment Gateway
Ultrasound Findings Decision Gateway
Maternal Optimization Status Gateway
Delivery Timing Decision Gateway
Surgical Preparation And Anesthesia Gateway
Placental Management Strategy Gateway
Post Operative Care Level Gateway
Future Pregnancy Counseling Gateway
First Trimester Scan Availability Gateway
CRL Measurement Validity Gateway
Assisted Reproductive Technology Status Gateway
Mean Sac Diameter Reliability Gateway
Second Third Trimester Transition Gateway
Third Trimester Only Scan Check Gateway
Skull Shape Variation Check Gateway
General Risk and Screening Assessment Gateway
Is The Uterine Scar Type Compatible With TOLAC
Are There Factors Increasing Uterine Rupture Risk
Is Induction Of Labour Required And What Agent Is Available
Are There Signs Of Labour Complications Or Rupture
Is Informed Consent And Documentation Complete
Is The Patient Entering The Active Labour Phase?
Is Induction Of Labour Indicated Or Requested?
Is The Patient Requiring Labour Augmentation Or Experiencing Suboptimal Contractility?
Is The Patient Considering Or Attempting A VBAC?
Is A Caesarean Birth Required (Planned Or Emergency)?
What Is The Patient's Weight/BMI For Antibiotic Dosing?
What Are The Anatomical Characteristics Of The Abdominal Wall?
Is The Subcutaneous Adipose Layer Greater Than 2 Cm In Thickness?
Are There Risk Factors For Venous Thromboembolism (VTE) Present?
Which Contraceptive Method Is Being Considered?
Is the patient in the pre-conception phase?
Has the patient had bariatric surgery?
What is the patient's risk profile for Neural Tube Defects (NTD)?
Does the patient meet Aspirin Prophylaxis criteria?
What is the patient's dietary calcium intake?
What is the pregnancy type and BMI?
Is the patient's BMI greater than or equal to 40 kg/m2?
Is the patient currently sedentary?
What is the current gestational age?
Does The Patient Present With High Risk Factors For Early Screening
Is The Patient Currently Within The Universal Screening Window Or Has Betamethasone Been Administered
Which Screening Approach Is Selected For The Patient
What Was The Result Of The Step 1 GCT
Are Glycemic Targets Achieved Through Non Medical Interventions
What Is The Fetal Growth Status Based On Ultrasound
Are There Comorbid Factors Requiring Enhanced Surveillance
What Is The Current Gestational Age And Clinical Status For Delivery
Has The Patient Entered The Postpartum Period
Is the Head Circumference (HC) less than or equal to 3 SD below the mean?
Does the patient have a previous affected pregnancy?
Are there maternal health risks or environmental exposures present?
Is there evidence of infectious markers or suspected congenital infection?
Does the patient meet criteria for Fetal Magnetic Resonance Imaging (MRI)?
What is the severity of the Head Circumference (HC) measurement?
What is the pregnancy outcome?
History Risk Assessment Gateway
Infection Screening Gateway
Prior Cervical Intervention History Gateway
Loss Count Threshold Gateway
Cervical Dilatation Measurement Gateway
Gestational Age For Emergency Gateway
Uterine Contractions Status Gateway
Prophylactic Timing Gateway
Alternative Therapy Consideration Gateway
Final Plan Confirmation Gateway
Is the primary indication for the visit related to pregnancy dating, viability, or suspected abortion
Is there clinical suspicion or risk factors for ectopic pregnancy, molar pregnancy, or pelvic masses
Is there a suspicion of multiple gestation
Is the patient scheduled for pregnancy termination or an invasive procedure
Is the patient within the 11 to 14 week window for genetic and anatomic screening
Was the Nuchal Translucency (NT) measurement greater than 3.5 mm
Is there a requirement for Preeclampsia risk assessment
Is The Patient's Environment Optimized For Hormonal Production
Does The Patient Require Immediate Physical Mobility Support
Which Neurophysiological Pain Modulation Approach Is Most Appropriate For The Current Pain Level
Is There A Medical Necessity For Synthetic Oxytocin
Has The Patient Reached Full Dilation
Is The Baby Descending Passively To The Vulva
Are There Absolute Contraindications to Vaccination in Pregnancy Present
Is The Patient Currently Suspected Or Documented To Have An Influenza Infection
What Is The Current Gestational Age Of The Patient
Is The Patient Susceptible To Hepatitis B With Associated Risk Factors
Does The Patient Have High-Risk Medical Conditions For Invasive Pneumococcal Disease (Ipd)
Is There A Need For Other Specialized Vaccines Based On Travel Or Exposure
Has The Patient Inadvertently Received A Live Or Live-Attenuated Vaccine During This Pregnancy
Is The Patient In The First Trimester Between 11 And 14 Weeks Gestation
Is There A Discrepancy Between The Last Menstrual Period And Available Ultrasound Data
Is The Patient Currently Between 38 And 41 Weeks Gestation
Has The Patient Reached 41 Plus 0 To 42 Plus 0 Weeks Gestation
Does The Patient Decline Induction Of Labour At 41 Plus 0 To 42 Plus 0 Weeks
Is The Patient Now At Or Beyond 42 Plus 0 Weeks Gestation
Are There Institutional Resource Constraints Or Specific Patient Values Or Beliefs That Require A Modified Approach
Is The Patient's Current HSV Status Known?
Is This A Primary HSV Infection Occurring In The Third Trimester?
Is The Gestational Age 36 Weeks Or Greater Or Is Preterm Delivery Anticipated?
Are There Active Lesions Or Prodromal Symptoms Present At The Time Of Labor?
Does The Neonate Exhibit Clinical Evidence Or Positive Culture More Than 48 Hours After Delivery?
Are There Active HSV Lesions On The Mother's Breast Postpartum?
Is The Patient In The Preconception Phase
Was A Comprehensive Investigation Performed At The Time Of The Index Stillbirth
Are There Specific Indicators For Targeted Maternal Testing
Does The Patient Meet Criteria For Antiphospholipid Antibody Apl Testing
Is The Patient At Risk For Placental Insufficiency
Is The Patient Currently Between 28 And 37 Weeks Gestation
Does The Patient Exhibit High-Risk Psychosocial Markers
Is The Patient Reaching Term Greater Than Or Equal To 37 Weeks
Is The Patient Exhibiting Signs Of Shock
What Is The Severity Of The Shock Stage
Is The Patient's Hemodynamic Status Unstable Or Is There A Need For Volume Expansion
Is There Evidence Of Significant Blood Loss Or Coagulopathy
Is The Patient Responding To Volume And Blood Replacement
Is There Evidence Of Delayed Or Occult Hemorrhage
Is The Delivery Method A Vaginal Birth Or An Elective Caesarean Section
Are There One Or More PPH Risk Factors Present
What Is The Gestational Age Of The Newborn
Has The Placenta Failed To Deliver Within 30 To 45 Minutes
Are There Clinical Markers Of Shock Present (Tachycardia, Diaphoresis, Hypotension, Or Oliguria)
Is The PPH Caused By Uterine Atony (Tone), Retained Tissue, Genital Tract Trauma, Or Coagulopathy (Thrombin)
Is The Patient Hemodynamically Stable And Unresponsive To Initial Medical Therapy
Are There Absolute Contraindications Present
Are There Relative Contraindications Present
What Is The Patients Prior Activity Level And Health Status
What Is The Patients Age For Heart Rate Targeting
Does The Patient Exhibit Specific Physical Or Environmental Risks
Is The Patient Currently Experiencing Red Flag Symptoms
Is The Patient In Active Labor
Are There Maternal Risk Factors Affecting Labor Duration
Is The First Stage Of Labor Progressing Normally
Is The Patient Requesting Pain Management
Is There A Need For Uterine Augmentation
Are There Risk Factors Requiring Low Dose Oxytocin
Is The Patient In The Second Stage With An Urge To Push
Is A Perineal Intervention Or Repair Required
Is Local Anesthesia Needed For Repair
Is The Third Stage Of Labor Complete
Is the patient's immune status known?
At what gestational age was immunity established or reinfection suspected?
Is the patient currently pregnant or planning pregnancy?
What is the current gestational age of the pregnancy?
Is the patient non-immune with a confirmed or suspected infection?
Was the patient inadvertently vaccinated during early pregnancy?
Is the patient currently postpartum?
Is The Patient Presenting With Prelabour Rupture Of Membranes Or Term Prelabour Rupture Of Membranes?
Are There Documented Risk Factors For Neonatal Gbs Disease Present?
Is There A Documented Penicillin Allergy Or History Of Anaphylaxis Risk Present?
Are There Specific Gbs Colonization Or Bacteriuria Indicators Present From Screening Or Prior History?
Is There Evidence Of Intrapartum Fever Or Clinical Chorioamnionitis Present?
Is Rapid Nucleic Acid Testing Or Susceptibility Data Required For Antibiotic Selection?
Is Intrapartum Intravenous Antibiotic Prophylaxis Indicated Based On The Combined Clinical Parameters?
Is Immediate Obstetrical Delivery Or Latency Management Required For Prelabour Rupture Of Membranes?
Is Neonatal Follow Up And Institutional Surveillance Required?
Is The Patient Currently Pregnant
Has The Pregnant Patient Been Exposed To Varicella
What Is The Immunity Status Of The Exposed Pregnant Patient
Are Serum Results Available Within 96 Hours Of Exposure
Does The Patient Develop An Active Varicella Rash
What Is The Severity Of The Maternal Infection
Is There Evidence Of Varicella Pneumonitis Or Severe Complications
When Is The Delivery Occurring Relative To Maternal Disease Onset
Is The Patient Currently At A Tertiary Care Center With Specialized Imaging Capabilities
What Is The Middle Cerebral Artery Mca Peak Systolic Velocity Result
Are There Maternal Risk Factors Or Lab Results Suggesting Specific Etiologies
Does The Genetic Or Chromosomal Analysis Indicate An Anomaly
Is There Evidence Of Fetal Cardiac Dysfunction Or Arrhythmia
What Is The Current Gestational Age And Fetal Stability
Has The Fetus Neonate Survived To Birth
Is The Quantitative Urine Culture Colony Count Threshold Met For Antepartum Treatment
Is Gbs Bacteriuria Documented In The Current Pregnancy
Is Recurrent Bacteriuria Identified After Initial Therapy Completion
Is Pre-Gestational Diabetes Present In The Maternal History
Are Chorioamnionitis Predictors Present During Labor Or Antepartum Care
Is Gbs Bacteriuria Combined With Additional Antibiotics For Other Infections Present
Is Third-Trimester Gbs Screening Requested Or Indicated
Is Clindamycin Or Erythromycin Susceptibility Confirmed For Gbs Treatment
Is the patient currently pregnant?
Does the patient meet high-risk criteria for screening for Toxoplasmosis?
What are the results of the initial serologic testing?
Is amniocentesis indicated for fetal assessment?
Is the timing appropriate for amniocentesis?
Is fetal infection confirmed or highly suspected?
Is the patient in the first trimester of pregnancy?
Has the patient entered the second trimester?
Is The Patients Medical Risk Profile Elevated?
What Is The Confirmed Gestational Age Via Ultrasound?
Is Cervical Preparation Indicated For This First Trimester Patient?
Is The Patient Undergoing Surgical Abortion Or Medical Abortion?
Are There Post-Procedural Complications Or Specific Contraception Needs?
Does The Patient Exhibit Signs Of Hemorrhage Or Uterine Perforation?
Did The Medical Induction Result In Complete Expulsion?
Does The Patient Meet Clinical Criteria For Gas Infection Requiring Urgent Workup
Is There Suspicion Of Necrotizing Fasciitis Based On Clinical Manifestations
Is There A Gynecologic Or Obstetric Source Of Infection Requiring Immediate Source Control
Is The Patient Presenting With Severe Gas Or Stss Requiring First-Line Antimicrobial Therapy
Does The Patient Have A Type 1 Penicillin Allergy Defined As Anaphylaxis
Is There A Penicillin And Cephalosporin Allergy Or A Concern For Mrsa
Is There A Concern For Clindamycin Resistance Based On Institutional Surveillance
Are Gram Stain And Culture Results Available For De-Escalation
Should Differential Diagnosis Include Clostridium Species In Pregnancy-Associated Necrotizing Soft Tissue Infections
What Is The Calculated BMI Value At The Initial Prenatal Visit
Are Any High-Risk Preeclampsia Factors Present
Are Two Or More Moderate-Risk Factors Present
Is Exactly One Moderate-Risk Factor Present Alongside Specific Demographic Considerations
Is The Current Gestational Age Within The Optimal Initiation Window
Are Standard 81 Mg Formulations Available
Is There A Clinical Consideration For Higher Dose Efficacy
Is Universal Prophylaxis Being Considered At The Practice Level
Is Checklist Deployment And Emr Integration Required
Is Multidisciplinary Team Assembly And Performance Monitoring Needed
Is the patient in the first trimester (less than 12 weeks)
Is the gestational age between 11 weeks and 14 weeks.
Has anatomy ultrasound been completed (usually between 18-20 weeks)
Has GDM testing been done
Is the gestational age greater than 24 weeks
Is patient Rh negative
Is the gestational age greater than 24 weeks
Is the gestational age greater than 28 weeks
Has GBS testing been done
Is patient less than 35 weeks
Is The Hemoglobin Level Below The Diagnostic Threshold For Iron Deficiency Anemia
Which Comprehensive Set Of Risk Factors Is Present To Influence Treatment Contraindications And Monitoring Needs
Which Specific Screening Protocol Or Investigation Timeline Applies To The Current Clinical Context
What Is The Severity Of Anemia And Which Clinical Indicators Dictate The Primary Treatment Modality
Which Intravenous Iron Formulation And Maximum Dosing Regimen Matches The Patient Gravid Status And Clinical Needs
What Type Of Adverse Reaction Or Monitoring Priority Requires Immediate Clinical Intervention During Intravenous Iron Administration
What Oral Iron Regimen And Dietary Optimization Strategy Is Appropriate Based On Tolerance And Formulation Requirements
Which Post-Treatment Monitoring Timeline And Duration Requirement Applies To The Selected Therapy
Are there current symptoms or history suggestive of spontaneous preterm birth risk
Is there a documented prior spontaneous preterm birth
Is there a multiple gestation
Is transvaginal ultrasound cervical length assessment available and performed
Is cervical length 25 mm or less in the current pregnancy
Is severe cervical shortening 20mm or less or cervical dilation present
Is the gestation multiple
Are there maternal symptoms or findings that require intensified safety monitoring during vaginal progesterone
Is a cervical pessary being considered for this patient
Is low dose aspirin being considered for this patient
Are Active Anorectal Or Urinary Symptoms Present
Is Wound Infection Or Acute Wound Complication Present
Are High Baseline Recurrent Oasi Risk Factors Present
Are Subsequent Delivery Intrapartum Risk Factors Present
Is The Patient At Least 6 Weeks Postpartum And Free Of Uncontrolled Acute Wound Infection
Are Structural Anal Sphincter Defects Identified On Available Ultrasound
Are Anorectal Manometry Or Dre Functional Findings Abnormal
Is The Patient At 28 Weeks Or Greater And Planning Or Contemplating Subsequent Vaginal Delivery
Enhanced Clinical Tools MCP Server
Available Clinical Decision Support Tools:
Gynecology Tools:
- cervical_cancer_screening - Cervical cancer screening recommendations
- fibroid_management_tool - Fibroid/leiomyoma management options
- dysmenorrhea_management_tool - Pelvic pain and dysmenorrhea management
Obstetrics Tools:
- didi_twins_tool - Dichorionic diamniotic twin management
- gbs_tool - Group B Streptococcus prophylaxis screening
- gdm_tool - Gestational diabetes testing
- hcv_prenatal_screening_tool - Hepatitis C prenatal screening
- icp_tool - Intrahepatic cholestasis of pregnancy management
- pertussis_tool - Pertussis vaccination eligibility
- pregnancy_calculator_tool - Pregnancy date calculations
- prenatal_genetic_screening_tool - Prenatal genetic screening for aneuploidy
- rhig_tool - RhoGAM immunoglobulin eligibility
Mental Health Tools:
- mental_health_meds_tool - Mental health medication options
- mental_health_screen_tool - Prenatal depression/anxiety screening
General Tools:
- risk_factor_tool - Risk factor assessment and counselling
All tools call clinical decision support APIs and return evidence-based recommendations.
⚠️ Important: All recommendations should be reviewed by qualified healthcare professionals and considered alongside complete patient history and clinical judgment.
MCP Connection Info:
- Server URL:
https://gjacob2010-mcp-server-r02.hf.space - Transport: SSE (Server-Sent Events)
- Compatible with: LM Studio, Claude Desktop, and other MCP-compatible clients